The FDA has approved Daytrana, the first skin patch as an alternative treatment for ADHD in children aged 6-12. It’s designed to be worn for 9 hours (originally submitted to the FDA as a longer-lasting delivery, they were asked to make it shorter), and releases the stimulant methylphenidate.
You can leave a response, or trackback from your own site.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 7 Apr 2006






